Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Monitor the Effects of the COVID-19 Vaccine on Cancer Patients Receiving Active Therapy (ANTICOV).

NCT04878796 is registered in ClinicalTrials.gov with Azienda Socio Sanitaria Territoriale di Cremona as lead sponsor.

NCT NCT04878796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04878796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Monitor the Effects of the COVID-19 Vaccine on Cancer Patients Receiving Active Therapy (ANTICOV).
Lead sponsor
Azienda Socio Sanitaria Territoriale di Cremona
Phase
Observational
Overall status
Unknown status
Start date
May 24, 2021
Completion date
May 31, 2022
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, covid-19, vaccine response